Recombinant Human Preferentially Expressed Antigen In Melanoma (PRAME), Unconjugated

Produktübersicht

• Artikelname: Recombinant Human Preferentially Expressed Antigen In Melanoma (PRAME), Unconjugated
• Artikelnummer: BIM-RPU43399
• Hersteller Artikelnummer: RPU43399
• Alternativnummer: BIM-RPU43399-50UG, BIM-RPU43399-100UG, BIM-RPU43399-1MG
• Hersteller: Biomatik Corporation
• Kategorie: Proteine/Peptide
• Applikation: Control, SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: MAPE, OIP4, CT130, Cancer/Testis Antigen 130, Opa-interacting protein 4, Melanoma antigen preferentially expressed in tumors

Produktbeschreibung

Recombinant Human Preferentially Expressed Antigen In Melanoma (PRAME) is a purified Prokaryotic Protein. Purity: >90% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Preferentia

Produkteigenschaften

• Molekulargewicht: 14/16kDa
• Tag: N-terminal His Tag
• NCBI: 23532
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Reinheit: >90% by SDS-PAGE
• Formulierung: Freeze-Dried Powder
• Target-Kategorie: Preferentially Expressed Antigen In Melanoma (PRAME)